Angiotensin inhibition and longevity: A question of hydration

Pflugers Archiv European Journal of Physiology

Volumn 461, Issue 3, 2011, Pages 317-324

  Thornton, Simon N ^a,b  

^a UNIVERSITÉ DE LORRAINE   (France)

^b INSERM   (France)

Author keywords

Angiotensin; Hydration; Longevity

Indexed keywords

3 METHOXY 2,6 DIMETHYL 4 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHOXY]PYRIDINE; ALDOSTERONE; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN II; RAMIPRIL;

AGING; ALDOSTERONE RELEASE; ALZHEIMER DISEASE; BLOOD PRESSURE REGULATION; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; FLUID BALANCE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYDRATION; HYPERTENSION; HYPOVOLEMIA; INSULIN RESISTANCE; KIDNEY DYSFUNCTION; LIFE EXPECTANCY; LONGEVITY; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESPIRATORY CHAIN; REVIEW; SURVIVAL TIME;

ANGIOTENSINS; DIABETES MELLITUS; DRINKING; HUMANS; HYPERTENSION; KIDNEY DISEASES; LONGEVITY; MITOCHONDRIA; OBESITY;

EID: 79953744513     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-010-0911-4     Document Type: Review

References (139)

1. Ayus JC, Arieff AI (1996) Abnormalities of water metabolism in the elderly. Semin Nephrol 16:277-288 (Pubitemid 26239457)
2. Baiardi G, Bregonzio C, Jezova M, Armando I, Saavedra JM (2004) Angiotensin II AT1 receptor blockade prolongs the lifespan of spontaneously hypertensive rats and reduces stress- induced release of catecholamines, glucocorticoids, and vasopressin. Ann NY Acad Sci 1018:131-136 (Pubitemid 38951399)
3. Barnett A (2006) Prevention of loss of renal function over time in patients with diabetic nephropathy. Am J Med 119:S40-S47
4. Basso N, Paglia N, Cini R, Inserra F, Terragno NA (2005) Effect of omapatrilat on the aging process of the normal rat. Cell Mol Biol (Noisy-le-grand) 51:557-564 (Pubitemid 41696413)
5. Basso N, Paglia N, Stella I, de Cavanagh EM, Ferder L, del Rosario Lores Arnaiz M, Inserra F (2005) Protective effect ofthe inhibition of the renin-angiotensin system on aging. Regul Pept 128:247-252 (Pubitemid 40544840)
6. Basso N, Cini R, Pietrelli A, Ferder L, Terragno NA, Inserra F (2007) Protective effect of long-term angiotensin II inhibition. Am J Physiol Heart Circ Physiol 293:H1351-H1358 (Pubitemid 47367173)
7. Bellisle F, Thornton SN, Hebel P, Denizeau M, Tahiri M (2010) A study offluid intake from beverages in a sample ofhealthy French children, adolescents and adults. EurJ Clin Nutr64:350-355
8. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G (2009) Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 119:524-530
9. Besdine RW, Wetle TF (2010) Improving health for elderly people: an international health promotion and disease prevention agenda. Aging Clin Exp Res 22:219-230
10. Brown MJ (2007) Renin: friend or foe? Heart 93:1026-1033 (Pubitemid 47310975)
11. Cadnapaphornchai MA, Rogachev B, Summer SN, Chen YC, Gera L, Stewart JM, Schrier RW (2004) Evidence for bradykinin as a stimulator of thirst. Am J Physiol Renal Physiol 286:F875-F880 (Pubitemid 38508988)
12. Carey RM, McGrath HE, Pentz ES, Gomez RA, Barrett PQ (1997) Biomechanical coupling in renin-releasing cells. J Clin Invest 100:1566-1574 (Pubitemid 27425784)
13. Carides GW, Shahinfar S, Dasbach EJ, Keane WF, Gerth WC, Alexander CM, Herman WH, Brenner BM, Investigators RENAAL (2006) The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy. Pharmacoeconomics 24:549-558 (Pubitemid 43886266)
14. Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ (2010) Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ 341:c4229
15. Cassis P, Conti S, Remuzzi G, Benigni A (2010) Angiotensin receptors as determinants of life span. Pflugers Arch 459:325-332
16. Chai W, Wang W, Liu J, Barrett EJ, Carey RM, Cao W, Liu Z (2010) Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 55:523-530
17. Chobanian AV (2009) Shattuck lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med 361:878-887
18. Chumlea WC, Guo SS, Zeller CM, Reo NV, Siervogel RM (1999) Total body water data for white adults 18 to 64 years of age: The Fels Longitudinal Study. Kidney Int 56:244-252 (Pubitemid 29300541)
19. Crowley RK, Sherlock M, Agha A, Smith D, Thompson CJ (2007) Clinical insights into adipsic diabetes insipidus: a large case series. Clin Endocrinol (Oxf) 66:475-482 (Pubitemid 46434924)
20. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB (2006) Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med 119:751-759 (Pubitemid 44308471)
21. Dauchet L, Amouyel P, Dallongeville J, Medscape (2009) Fruits, vegetables and coronary heart disease. Nat Rev Cardiol 6:599-608
22. de Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L, Fraga CG (2003) Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17:1096-1098
23. de Cavanagh EM, Piotrkowski B, Fraga CG (2004) Concerted action of the renin-angiotensin system, mitochondria, and antioxidant defenses in aging. Mol Aspects Med 25:27-36 (Pubitemid 38401929)
24. de Cavanagh EM, Toblli JE, Ferder L, Piotrkowski B, Stella I, Fraga CG, Inserra F (2005) Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats. Cell Mol Biol (Noisy-le-grand) 51:573-578 (Pubitemid 41696415)
25. de Cavanagh EM, Inserra F, Ferder M, Ferder L (2007) From mitochondria to disease: role of the renin-angiotensin system. Am J Nephrol 27:545-553 (Pubitemid 350014941)
26. de Cavanagh EM, Ferder L, Toblli JE, Piotrkowski B, Stella I, Fraga CG, Inserra F (2008) Renal mitochondrial impairment is attenuated by AT1 blockade in experimental Type I diabetes. Am J Physiol Heart Circ Physiol 294:H456-H465
27. de Cavanagh EM, Flores I, Ferder M, Inserra F, Ferder L (2008) Renin-angiotensin system inhibitors protect against age-related changes in rat liver mitochondrial DNA content and gene expression. Exp Gerontol 43:919-928
28. de Cavanagh EM, Ferder M, Inserra F, Ferder L (2009) Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol 296:H550-H558
29. Elamin A, Hussein O, Tuvemo T (2006) Growth, puberty, and final height in children with Type 1 diabetes. J Diabetes Complications 20:252-256
30. Ferder LF, Inserra F, Basso N (2002) Advances in our understanding of aging: role of the renin-angiotensin system. Curr Opin Pharmacol 2:189-194 (Pubitemid 34296450)
31. Ferder LF, Inserra F, Basso N (2003) Effects of renin-angiotensin system blockade in the aging kidney. Exp Gerontol 38:237-244 (Pubitemid 36170318)
32. Fetissov SO, Thornton SN (2009) Hypovolemia-induced obesity and diabetes. Metabolism 58:1678
33. Fitzsimons JT (1998) Angiotensin, thirst, and sodium appetite. Physiol Rev 78:583-686 (Pubitemid 28340599)
34. Formenti F, Constantin-Teodosiu D, Emmanuel Y, Cheeseman J, Dorrington KL, Edwards LM, Humphreys SM, Lappin TR, McMullin MF, McNamara CJ, Mills W, Murphy JA, O'Connor DF, Percy MJ, Ratcliffe PJ, Smith TG, Treacy M, Frayn KN, Greenhaff PL, Karpe F, Clarke K, Robbins PA (2010) Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci USA 107:12722-12727
35. Francischetti EA, Celoria BM, Francischetti A, Genelhu VA (2008) Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan. Expert Rev Cardiovasc Ther 6:289-303
36. Franklin RM, Kanaley JA (2009) Intramyocellular lipids: effect of age, obesity, and exercise. Phys Sportsmed 37:20-26
37. Gard PR (2004) Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression. Expert Opin Ther Targets 8:7-14 (Pubitemid 38240020)
38. Gaster M (2009) Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects. Biochem Biophys Res Commun 382:766-770
39. Gilliam-Davis S, Payne VS, Kasper SO, Tommasi EN, Robbins ME, Diz DI (2007) Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats. Am J Physiol Heart Circ Physiol 293:H1327-H1333 (Pubitemid 47367170)
40. Gnudi L, Goldsmith D (2010) Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention ofearly renal disease in diabetes. F1000 Med Rep 2:18
41. Gradman AH, Kad R (2008) Renin inhibition in hypertension. J Am Coll Cardiol 51:519-528
42. Haussinger D (1996) The role of cellular hydration in the regulation of cell function. Biochem J 313:697-710 (Pubitemid 26050797)
43. Haveman-Nies A, de Groot LC, Van Staveren WA (1997) Fluid intake of elderly Europeans. J Nutr Health Aging 1:151-155 (Pubitemid 127721581)
44. Hedner T, Narkiewicz K, Kjeldsen SE (2007) The evolution of ACE inhibition-a turning point in cardiovascular medicine. Blood Press Suppl 2:5-6
45. Henriksen EJ (2007) Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 293:R974-R980 (Pubitemid 47358914)
46. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L, Williams B (2008) Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res 102:201-208 (Pubitemid 351651124)
47. Hirabara SM, Curi R, Maechler P (2010) Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J Cell Physiol 222:187-194
48. Idbaih A, Burlet A, Adle-Biassette H, Boisgard R, Coulon C, Paris S, Marie Y, Donadieu J, Hoang-Xuan K, Ribeiro MJ (2007) Altered cerebral glucose metabolism in an animal model of diabetes insipidus: a micro-PET study. Brain Res 1158:164-168 (Pubitemid 47068413)
49. Inserra F, Basso N, Ferder M, Userpater M, Stella I, Paglia N, Inserra P, Tenembaum D, Ferder L (2009) Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system. Ther Adv Cardiovasc Dis 3:341-346
50. Janiak P, Bidouard JP, Cadrouvele C, Poirier B, Gouraud L, Grataloup Y, Pierre F, Bruneval P, O'Connor SE, Herbert JM (2006) Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats. Eur J Pharmacol 534:271-279 (Pubitemid 43384210)
51. Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, Egan GF, McKinley MJ, Rodger PD, Sinclair AJ, Wark JD, Weisinger HS, Jois M, Weisinger RS (2008) Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 105:6531-6536 (Pubitemid 351754541)
52. Jordan J (2002) Acute effect of water on blood pressure. What do we know? Clin Auton Res 12:250-255
53. Kehoe PG, Miners S, Love S (2009) Angiotensins in Alzheimer's disease - friend or foe? Trends Neurosci 32:619-628
54. Keller U, Szinnai G, Bilz S, Berneis K (2003) Effects of changes in hydration on protein, glucose and lipid metabolism in man: impact on health. Eur J Clin Nutr 57:S69-S74 (Pubitemid 38159631)
55. Kenney WL, Chiu P (2001) Influence of age on thirst and fluid intake. Med Sci Sports Exerc 33:1524-1532 (Pubitemid 32831443)
56. Kositzke JA (1990) A question of balance-dehydration in the elderly. J Gerontol Nurs 16:4-11
57. Lang F (2007) Mechanisms and significance of cell volume regulation. J Am Coll Nutr 26:613S-623S (Pubitemid 47512057)
58. Lang F, Ritter M, Völkl H, Häussinger D (1993) The biological significance of cell volume. Ren Physiol Biochem 16:48-65 (Pubitemid 23136485)
59. Lanza IR, Nair KS (2010) Mitochondrial function as a determinant of life span. Pflugers Arch 459:277-289
60. Laragh J (2001) Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 14:84-89
61. Laragh J (2001) Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 14:837-854 (Pubitemid 32862582)
62. Laragh J (2001) Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 14:296-304 (Pubitemid 32203721)
63. Lavizzo-Mourey RJ (1987) Dehydration in the elderly: a short review. J Natl Med Assoc 79:1033-1038 (Pubitemid 18055079)
64. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340:b5465
65. Linz W, Jessen T, Becker RH, Schölkens BA, Wiemer G (1997) Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 96:3164-3172 (Pubitemid 27500122)
66. Linz W, Becker RH, Scholkens BA, Wiemer G, Keil M, Langer KH (1998) Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats. Kidney Int 54:2037-2044 (Pubitemid 28533632)
67. Linz W, Wohlfart P, Schoelkens BA, Becker RH, Malinski T, Wiemer G (1999) Late treatment with ramipril increases survival in old spontaneously hypertensive rats. Hypertension 34:291-295 (Pubitemid 29409230)
68. Linz W, Heitsch H, Schölkens BA, Wiemer G (2000) Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats. Hypertension 35:908-913 (Pubitemid 30303949)
69. Ma TK, Kam KK, Yan BP, Lam YY (2010) Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 160:1273-1292
70. Majzoub JA, Srivatsa A (2006) Diabetes insipidus: clinical and basic aspects. Pediatr Endocrinol Rev 4:60-65 (Pubitemid 46224447)
71. Mathai ML, Naik S, Sinclair AJ, Weisinger HS, Weisinger RS (2008) Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int J Obes (Lond) 32:1576-1584
72. Mattson MP, Maudsley S (2009) Live longer sans the AT1A receptor. Cell Metab 9:403-405
73. May M, Jordan J (2010) The Osmopressor-response to water drinking. Am J Physiol Regul Integr Comp Physiol Nov 3. (in press)
74. Miller M (1997) Fluid and electrolyte homeostasis in the elderly: physiological changes of ageing and clinical consequences. Baillières Clin Endocrinol Metab 11:367-387 (Pubitemid 27485032)
75. Mizrahi A, Knekt P, Montonen J, Laaksonen MA, Heliövaara M, Järvinen R (2009) Plant foods and the risk of cerebrovascular diseases: a potential protection of fruit consumption. Br J Nutr 102:1075-1083
76. Mogi M, Horiuchi M (2009) Effects of angiotensin II receptor blockers on dementia. Hypertens Res 32:738-740
77. Molaschi M, Ponzetto M, Massaia M, Villa L, Scarafiotti C, Ferrario E (1997) Hypernatremic dehydration in the elderly on admission to hospital. J Nutr Health Aging 1:156-160 (Pubitemid 127721582)
78. Molteni A, Heffelfinger S, Moulder JE, Uhal B, Castellani WJ (2006) Potential deployment of angiotensin I converting enzyme inhibitors and of angiotensin II type 1 and type 2 receptor blockers in cancer chemotherapy. Anticancer Agents Med Chem 6:451-460 (Pubitemid 44377779)
79. Morino K, Petersen KF, Shulman GI (2006) Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55:S9-S15 (Pubitemid 44927027)
80. Moscarelli L, Zanazzi M, Mancini G, Rossi E, Caroti L, Rosso G, Bertoni E, Salvadori M (2010) Keratinocyte cancerprevention with ACE inhibitors, angiotensin receptorblockers ortheircombination in renal transplant recipients. Clin Nephrol 73:439-445
81. Munoz MC, Argentino DP, Dominici FP, Turyn D, Toblli JE (2006) Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens 24:1607-1617 (Pubitemid 44162463)
82. Nagura J, Hui C, Yamamoto M, Yasuda S, Abe M, Hachisu M, Konno F (1995) Effect of chronic treatment with ME3221 on blood pressure and mortality in aged stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol Suppl 22:S363-S365 (Pubitemid 26064500)
83. Nagura J, Yamamoto M, Hui C, Yasuda S, Hachisu M, Konno F (1996) Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 23:229-235
84. Nangaku M, Fujita T (2008) Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertens Res 31:175-184 (Pubitemid 351461095)
85. Nayak V, Patil PA (2008) Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice. Indian J Exp Biol 46:180-184
86. Niklason A, HednerT, Niskanen L, Lanke J (2004) Development of diabetes is retarded by ACE inhibition in hypertensive patients-a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens 22:645-652 (Pubitemid 38368500)
87. Nishiyama A, Matsusaka T, Miyata T (2009) Angiotensin II type 1A receptor deficiency and longevity. Nephrol Dial Transplant 24:3280-3281
88. Nissen SE (2010) Angiotensin-receptor blockers and cancer: urgent regulatory review needed. Lancet Oncol 11:605-606
89. Parish R, Petersen KF (2005) Mitochondrial dysfunction and type 2 diabetes. Science 5:384-387
90. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142 (Pubitemid 36583097)
91. Phillips PA, Rolls BJ, Ledingham JG, Forsling ML, Morton JJ, Crowe MJ, Wollner L (1984) Reduced thirst after water deprivation in healthy elderly men. N Engl J Med 311:753-759 (Pubitemid 14026225)
92. Portero-Otín M, Pamplona R, Boada J, Jové M, Gonzalo H, Buleon M, Linz W, Schäfer S, Tack I, Girolami JP (2008) Inhibition of renin angiotensin system decreases renal protein oxidative damage in diabetic rats. Biochem Biophys Res Commun 368:528-535
93. Raffaello A, Rizzuto R (2010) Mitochondrial longevity pathways. Biochim Biophys Acta Oct 13. (in press)
94. Reinehr T (2005) Clinical presentation of type 2 diabetes mellitus in children and adolescents. Int J Obes (Lond) 29:S105-S110
95. Rink TJ (1984) Aspects of the regulation of cell volume. J Physiol (Paris) 79:388-394 (Pubitemid 15120605)
96. Ritz P (2001) Chronic cellular dehydration in the aged patient. J Gerontol A Biol Sci Med Sci 56:M349-M352 (Pubitemid 32522252)
97. Ritz P, Vol S, Berrut G, Tack I, Arnaud MJ, Tichet J (2008) Influence of gender and body composition on hydration and body water spaces. Clin Nutr 27:740-746
98. Rogge MM (2009) The role of impaired mitochondrial lipid oxidation in obesity. Biol Res Nurs 10:356-373
99. Rolls BJ, Phillips PA (1990) Aging and disturbances of thirst and fluid balance. Nutr Rev 48:137-144 (Pubitemid 20078430)
100. Rosen RC, Wing RR, Schneider S, Wadden TA, Foster GD, West DS, Kitabchi AE, Brancati FL, Maschak-Carey BJ, Bahnson JL, Lewis CE, Gendrano Iii IN (2009) Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med 6:1414-1422
101. Rosenthal T, Gavras I (2009) Angiotensin inhibition and malignancies: a review. J Hum Hypertens 23:623-635
102. Ruilope LM, Segura J (2003) Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. Clin Ther 25:3044-3064 (Pubitemid 38096144)
103. Saavedra JM, Ando H, Armando I, Baiardi G, Bregonzio C, Juorio A, Macova M (2005) Anti-stress and anti-anxiety effects of centrally acting angiotensin IIAT1 receptor antagonists. Regul Pept 128:227-238 (Pubitemid 40544838)
104. Safar ME (2010) Can antihypertensive treatment reverse large- artery stiffening? Curr Hypertens Rep 12:47-51
105. Safar ME, Temmar M, Kakou A, Lacolley P, Thornton SN (2009) Sodium intake and vascular stiffness in hypertension. Hypertension 54:203-209
106. Santos EL, de Picoli SK, da Silva ED, Batista EC, Martins PJ, D'Almeida V, Pesquero JB (2009) Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats. Biochem Pharmacol 78:951-958
107. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A (2008) Renin- angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 26:831-843 (Pubitemid 351540757)
108. Savage DB, Petersen KF, Shulman GI (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507-520 (Pubitemid 47084679)
109. Scheen AJ (2004) Prevention of type 2 diabetes mellitus through inhibition ofthe Renin-Angiotensin system. Drugs 64:2537-2565 (Pubitemid 39591650)
110. Scheen AJ (2004) Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms. Diabetes Metab 30:498-505 (Pubitemid 40073639)
111. Schliess F, Haussinger D (2000) Cell hydration and insulin signalling. Cell Physiol Biochem 10:403-408 (Pubitemid 32008924)
112. Schliess F, Häussinger D (2003) Call volume and insulin signaling. Int Rev Cytol 225:187-228
113. Schliess F, Richter L, vom Dahl S, Haussinger D (2006) Cell hydration and mTOR-dependent signalling. Acta Physiol (Oxf) 187:223-229 (Pubitemid 43828780)
114. Seeliger E, Wronski T, Ladwig M, Dobrowolski L, Vogel T, Godes M, Persson PB, Flemming B (2009) The renin-angiotensin system and the third mechanism of renal blood flow autoregulation. Am J Physiol Ren Physiol 296:F1334-F1345
115. Seng WK, Hwang SJ, Han DC, Teong CC, Chan J, Burke TA, Carides GW, Choi YJ (2005) Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective. Nephrology (Carlton) 10:520-524 (Pubitemid 41727280)
116. Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N, Association AD (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186-212 (Pubitemid 40095803)
117. Sjögren P, Becker W, Warensjö E, Olsson E, Byberg L, Gustafsson IB, Karlström B, Cederholm T (2010) Mediterranean and carbohydrate- restricted diets and mortality among elderly men: a cohort study in Sweden. Am J Clin Nutr 92:967-974
118. Stookey JD (2005) High prevalence of plasma hypertonicity among community-dwelling older adults: results from NHANES III. J Am Diet Assoc 105:1231-1239 (Pubitemid 41058838)
119. Stookey JD, Barclay D, Arieff A, Popkin BM (2007) The altered fluid distribution in obesity may reflect plasma hypertonicity. Eur J Clin Nutr 61:190-199
120. Stookey JD, Constant F, Popkin BM, Gardner CD (2008) Drinking water is associated with weight loss in overweight dieting women independent of diet and activity. Obesity (Silver Spring) 16:2481-2488
121. Struthers A, Krum H, Williams GH (2008) A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol 31:153-158 (Pubitemid 351556480)
122. Stucchi P, Cano V, Ruiz-Gayo M, Fernández-Alfonso MS (2009) Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity. Br J Pharmacol 158:771-778
123. Takahashi N, Lopez ML, Cowhig JE Jr, Taylor MA, Hatada T, Riggs E, Lee G, Gomez RA, Kim HS, Smithies O (2005) Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J Am Soc Nephrol 16:125-132 (Pubitemid 43073164)
124. Takai S, Jin D, Ikeda H, Sakonjo H, Miyazaki M (2009) Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats. Hypertens Res 32:853-860
125. Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, Kano M, Ogihara T, Rakugi H, Morishita R (2009) Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 54:1345-1352
126. Thornton SN (2009) Angiotensin, the hypovolaemia hormone, aggravates hypertension, obesity, diabetes and cancer. J Intern Med 265:616-617
127. Thornton SN (2009) Hypovolaemia-induced mild hypoxia produces subchronic metabolic dysfunction. Int J Obes (Lond) 33:605
128. Thornton SN (2009) Angiotensin, the hormone to be blocked by antithypertensive drugs, and perhaps why they don't work. Curr Vasc Pharmacol 7:549
129. Thornton SN (2010) Thirst and hydration: physiology and consequences of dysfunction. Physiol Behav 100:15-21
130. Thornton SN (2010) Angiotensin antagonists could increase urine production and drinking in order to decrease renal problems in diabetes and hypertension. Hypertens Res 33:88
131. Thornton SN, Even PC, van Dijk G (2009) Hydration increases cell metabolism. Int J Obes (Lond) 33:385
132. Van Buren PN, Adams-Huet B, Toto RD (2010) Effective antihypertensive strategies for high-risk patients with diabetic nephropathy. J Investig Med Oct 27. (in press)
133. van Lieburg AF, Knoers NV, Monnens LA (1999) Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 10:1958-1964
134. Waldegger S, Busch GL, Kaba NK, Zempel G, Ling H, Heidland A, Häussinger D, Lang F (1997) Effect of cellular hydration on protein metabolism. Miner Electrolyte Metab 23:201-205 (Pubitemid 27475345)
135. Weisinger RS, Begg DP, Chen N, Jois M, Mathai ML, Sinclair AJ (2007) The problem of obesity: is there a role for antagonists of the renin-angiotensin system? Asia Pac J Clin Nutr 16:359-367 (Pubitemid 46524629)
136. Weisinger HS, Begg DP, Egan GF, Jayasooriya AP, Lie F, Mathai ML, Sinclair AJ, Wark JD, Weisinger RS (2008) Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol Behav 93:820-825 (Pubitemid 351381081)
137. Weisinger RS, Begg DP, Jois M (2009) Antagonists of the renin- angiotensin system and the prevention of obesity. Curr Opin Investig Drugs 10:1069-1077
138. Weisinger RS, Stanley TK, Begg DP, Weisinger HS, Spark KJ, Jois M (2009) Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol Behav 98:192-197
139. Zou K, Michikawa M (2008) Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation? Rev Neurosci 19:203-212